文献速递慢性肾脏病

年轻健康体检者边缘性eGFR与心血管及死亡风险

Cardiovascular and Mortality Risks in Young Health Screening Examinees With Marginal Estimated GFR.
PubMed 文献 · Kidney Int Rep · 2023-09-07

韩国全国性回顾性队列纳入2012年接受健康筛查的20-39岁无MACE或肾衰竭史的3132409名年轻人,按eGFR每15 ml/min per 1.73 m2分层。中位随访7.3年,边缘性eGFR(60-75)与全因死亡(aHR 0.80 [0.74-0.87])及MACE(aHR 0.94 [0.87-1.01])风险升高无关;尿白蛋白阳性者亦然(aHR 0.98 [0.62, 1.55])。

要点

  • 年轻一般人群中边缘性eGFR(60-75)未显示与全因死亡或MACE风险升高相关。
  • 尿白蛋白阳性与eGFR分类对全因死亡存在交互(P=0.028),但该亚组风险未显著升高。
  • 对一般年轻人偶然发现的边缘性eGFR,可能不建议额外临床检查。

核心结论

  • 在一般年轻成人中,边缘性eGFR与全因死亡和MACE风险升高无关。
  • 对一般年轻人偶然发现的边缘性eGFR值,可能不鼓励进行额外临床检查。

研究设计与样本

  • 韩国全国性回顾性队列研究,使用健康筛查数据库。
  • 纳入2012年接受全国健康筛查、20-39岁、无MACE或肾衰竭史的年轻人。
  • 暴露为按15 ml/min per 1.73 m2区间分类的eGFR,采用Cox回归并校正临床人口学特征。

主要发现

  • 共纳入3132409名年轻人,中位随访7.3年。
  • 边缘性eGFR(60-75 ml/min per 1.73 m2)与全因死亡风险无关(aHR 0.80 [0.74-0.87])。
  • MACE结果相似(aHR 0.94 [0.87-1.01])。
  • 尿白蛋白阳性与eGFR分类对全因死亡存在显著交互(交互项P=0.028)。
  • 尿白蛋白阳性且eGFR 60-75者全因死亡风险未显著升高(aHR 0.98 [0.62, 1.55])。

临床怎么用

  • 解读年轻成人边缘性eGFR时可参考:一般人群未见死亡或MACE风险升高。
  • 对无其他异常的年轻体检者,边缘性eGFR不宜直接视为高危信号。
  • 合并尿白蛋白阳性者仍需结合临床综合评估。

局限性

  • 为回顾性观察性研究,不能证明因果。
  • 仅纳入韩国20-39岁健康筛查人群,外推需谨慎。
  • 随访中位7.3年,长期结局未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Additional evidence is necessary to interpret kidney function parameters in young adults, particularly in those with marginal estimated glomerular filtration rate (eGFR) values. Therefore, we aimed to investigate the association between eGFR and adverse outcomes in general young adults. METHODS: We performed a nationwide retrospective cohort study using the health-screening database of South Korea. We included young adults aged 20-39 years without a history of major adverse cardiovascular events (MACE) or kidney failure, who underwent nationwide health screening in 2012. The study exposure was eGFR categorized into 15 ml/min per 1.73 m2 intervals. The risks of all-cause mortality and MACE were calculated using Cox regression analysis, adjusted for various clinicodemographic characteristics. RESULTS: In total, 3,132,409 young adults were included in this study. During a median follow-up of 7.3 years, marginal eGFR (60-75 ml/min per 1.73 m2) was not significantly associated with a higher risk of all-cause mortality (adjusted hazard ratio [aHR], 0.80 [0.74-0.87]). The results were similar for MACE outcomes (aHR, 0.94 [0.87-1.01]). Although the presence of dipstick albuminuria had a significant interaction with the association between eGFR categories and all-cause mortality (interaction term P = 0.028), the risks of all-cause mortality were not significantly higher (aHR, 0.98 [0.62, 1.55]) in those with albuminuria and eGFR 60-75 ml/min per 1.73 m2. CONCLUSION: Marginal eGFR was not associated with higher risks of all-cause mortality and MACE in general young adults. Additional clinical investigations for incidentally found marginal eGFR values may be discouraged in general young adults.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Kim M, Han K, Joo KW, et al. Cardiovascular and Mortality Risks in Young Health Screening Examinees With Marginal Estimated GFR. Kidney Int Rep. 2023. PMID: 38106592. doi:10.1016/j.ekir.2023.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。